Aurora Cannabis Reports Strong Q2 Growth Driven By International Medical Marijuana Sales - Aurora Cannabis ( NASDAQ:ACB )
Canadian medical marijuana giant Aurora Cannabis Inc. ACB ACB reported its financial results Wednesday for the second quarter of fiscal 2025, showing revenue of CA$81.1 million ( $58.3 million ) , up from CA$63.1 million in the same period last year.
| Ticker |
Sentiment |
Impact |
|
ACB
|
Neutral
|
17 %
|
|
MJNA
|
Neutral
|
6 %
|
|
SSTK
|
Somewhat Bullish
|
6 %
|
